Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Sinovac Files to Start Clinical Trial of Infant Pneumococcal Vaccine

publication date: Mar 3, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sinovac Biotech has filed an application with the SFDA to begin clinical trials of its 13-valent pneumococcal conjugate vaccine (PCV). The target market for the vaccine is infants under the age of two, a population that currently numbers 34 million in China. Sinovac also anticipates participating in a United Nations program that supplies PCV to developing nations. More details....

Stock Symbol: (NSDQ: SVA)



Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners